Preoperative Gut Microbiome Profiling Linking Microbial Signatures to Anastomotic Leakage Risk

• Challenge assumptions around clinical endpoints and trial design to improve translational success
• Address cost-of-goods and production scalability to unlock sustainable development pathways
• Reframe the probiotic–drug divide to clarify modality, mechanism, and market potential

Speakers:

Konstantina Zafeiropoulou

Postdoctoral researcher

Amsterdam Neuroscience - Industry Alliance Office